WallStSmart
DTIL

Precision BioSciences Inc

NASDAQ: DTIL · HEALTHCARE · BIOTECHNOLOGY

$7.28
-3.77% today

Updated 2026-11-16

Market cap
$288.76M
P/E ratio
30.26
P/S ratio
6.41x
EPS (TTM)
$0.25
Dividend yield
—
52W range
$4 – $11
Volume
0.3M

Precision BioSciences Inc (DTIL) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$7.28
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$9.38

Financial forecast

Metric20212022202320242025
Revenue$0.1B$0.0B$0.0B$0.1B$0.0B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -85.60%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.